These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

867 related articles for article (PubMed ID: 30463533)

  • 1. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
    Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
    BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
    Chen RF; Li J; Zhu TT; Yu HL; Lu X
    J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncofertility outcomes after fertility-sparing treatment of bilateral serous borderline ovarian tumors: results of a large retrospective study.
    Jia SZ; Xiang Y; Yang JJ; Shi JH; Jia CW; Leng JH
    Hum Reprod; 2020 Feb; 35(2):328-339. PubMed ID: 32048711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
    Vasconcelos I; de Sousa Mendes M
    Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salpingo-oophorectomy versus cystectomy in patients with borderline ovarian tumors: a systemic review and meta-analysis on postoperative recurrence and fertility.
    Wang P; Fang L
    World J Surg Oncol; 2021 Apr; 19(1):132. PubMed ID: 33882931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].
    Canlorbe G; Lecointre L; Chauvet P; Azaïs H; Fauvet R; Uzan C
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):287-303. PubMed ID: 32004786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of borderline ovarian tumours.
    Gershenson DM
    Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():49-59. PubMed ID: 27780698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unilateral cystectomy and serous histology are associated with relapse in borderline ovarian tumor patients with fertility-sparing surgery: a systematic review and meta-analysis.
    Li N; Ming X; Li Z
    Arch Gynecol Obstet; 2020 Nov; 302(5):1063-1074. PubMed ID: 32748055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncologic and reproductive outcomes after fertility-sparing surgery for bilateral borderline ovarian tumors: A retrospective study.
    Guo L; Kang X; Su Y; Liu X; Xie W; Meng S; Liu Y; Wang W; Wang C
    Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():107-113. PubMed ID: 38422803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study.
    Zhao J; Wang D; Wang R; He Y; Jia C; Pan L; Ma S; Wu M; Wang W; Cheng X; Yang J; Xiang Y
    J Ovarian Res; 2024 May; 17(1):96. PubMed ID: 38720349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of fertility-sparing surgery and further prognostic factors in borderline tumors of the ovary.
    Westermann T; Karabeg E; Heitz F; Traut A; Plett H; Moubarak M; Welz J; Heikaus S; Lax S; du Bois A; Harter P
    Int J Gynecol Cancer; 2024 Jun; 34(6):898-905. PubMed ID: 38627034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery.
    Delle Marchette M; Ceppi L; Andreano A; Bonazzi CM; Buda A; Grassi T; Giuliani D; Sina F; Lamanna M; Bianchi T; Lissoni AA; Landoni F; Valsecchi MG; Fruscio R
    Eur J Cancer; 2019 Apr; 111():61-68. PubMed ID: 30826658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors.
    Yinon Y; Beiner ME; Gotlieb WH; Korach Y; Perri T; Ben-Baruch G
    Fertil Steril; 2007 Aug; 88(2):479-84. PubMed ID: 17408624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncological and Reproductive Outcomes of Cystectomy Compared with Unilateral Salpingo-Oophorectomy as Fertility-Sparing Surgery in Patients with Apparent Early Stage Pure Immature Ovarian Teratomas.
    Wang D; Zhu S; Jia C; Cao D; Yang J; Xiang Y
    Ann Surg Oncol; 2021 Oct; 28(11):6684-6693. PubMed ID: 33772392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic and reproductive outcomes of cystectomy as a fertility-sparing treatment for early-stage epithelial ovarian cancer.
    Kajiyama H; Suzuki S; Niimi K; Tamauchi S; Kawai M; Nagasaka T; Shibata K; Kikkawa F
    Int J Clin Oncol; 2019 Jul; 24(7):857-862. PubMed ID: 30771039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome.
    Candotti G; Peiretti M; Mangili G; Bergamini A; Candiani M; Cioffi R; Mais V; Rabaiotti E; Bocciolone L
    Eur J Surg Oncol; 2020 May; 46(5):888-892. PubMed ID: 31722834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
    Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
    J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy.
    Schilder JM; Thompson AM; DePriest PD; Ueland FR; Cibull ML; Kryscio RJ; Modesitt SC; Lu KH; Geisler JP; Higgins RV; Magtibay PM; Cohn DE; Powell MA; Chu C; Stehman FB; van Nagell J
    Gynecol Oncol; 2002 Oct; 87(1):1-7. PubMed ID: 12468335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.